28274163|t|Biomarkers for predicting spontaneous preterm birth: an umbrella systematic review
28274163|a|To identify all systematic reviews investigating the role of maternal and fetal biomarkers for predicting spontaneous preterm birth (SPTB). Medline and Web of Sciences databases were searched electronically. Studies exploring the association between maternal biomarkers and spontaneous delivery were considered suitable for inclusion. A synthesis of the systematic reviews was performed with the umbrella methodology. Statistical measures of association (Odd ratio, OR, relative risk, RR) and predictive accuracy (sensitivity, specificity, positive and negative likelihood ratios were used to synthesize results of the included studies. 21,614 articles were identified, 542 were assessed with respect to their eligibility for inclusion and 14 systematic reviews included. Cervical fibronectin was the biomarkers which showed the highest strength of association with the occurrence of SPTB (delivery within 24 h OR 7, 95%CI 3-17; delivery <7 days (OR 12, 95%CI 8-16). Maternal serum alpha fetoprotein, was associated with an OR of 4 and 3 for early and late SPTB. C-reactive protein had an OR of 2 (95%CI 1-2) and 8 (95%CI 4-16) when detected in maternal plasma and amniotic fluid, respectively. Among cytokines, interleukin-6 had an OR and an LR + for SPTB of 2 and 12 when detected in maternal serum. Cervical fetal fibronectin, alpha fetoprotein, C- reactive protein and interleukin 6 can have an overall good diagnostic accuracy in identifying pregnancies at risk of SPTB. Large prospective studies in different sub-set of women are needed to ascertain whether the combination of different serological and imaging marker can improve antenatal prediction of this condition.
28274163	0	10	Biomarkers	T201	C0005516
28274163	15	25	predicting	T078	C0681842
28274163	26	51	spontaneous preterm birth	T033	C3827961
28274163	56	82	umbrella systematic review	T170	C1955832
28274163	99	117	systematic reviews	T170	C1955832
28274163	118	131	investigating	T169	C1292732
28274163	144	152	maternal	T033	C1858460
28274163	157	162	fetal	T169	C0521457
28274163	163	173	biomarkers	T201	C0005516
28274163	178	188	predicting	T078	C0681842
28274163	189	214	spontaneous preterm birth	T033	C3827961
28274163	216	220	SPTB	T033	C3827961
28274163	223	230	Medline	T170	C0025141
28274163	235	260	Web of Sciences databases	T170	C0242356
28274163	291	298	Studies	T062	C2603343
28274163	313	324	association	T067	C0596306
28274163	333	341	maternal	T033	C1858460
28274163	342	352	biomarkers	T201	C0005516
28274163	357	377	spontaneous delivery	T040	C1389695
28274163	407	416	inclusion	T080	C1512693
28274163	420	429	synthesis	T052	C1883254
28274163	437	455	systematic reviews	T170	C1955832
28274163	460	469	performed	T169	C0884358
28274163	479	499	umbrella methodology	T078	C3266812
28274163	501	521	Statistical measures	T081	C0871425
28274163	525	536	association	T067	C0596306
28274163	538	547	Odd ratio	T081	C0028873
28274163	549	551	OR	T081	C0028873
28274163	553	566	relative risk	T081	C0242492
28274163	568	570	RR	T081	C0242492
28274163	576	586	predictive	T080	C0681890
28274163	587	595	accuracy	T080	C0443131
28274163	597	608	sensitivity	T081	C0036667
28274163	610	621	specificity	T081	C0037791
28274163	623	662	positive and negative likelihood ratios	T081	C0150102
28274163	676	686	synthesize	T052	C1883254
28274163	687	694	results	T169	C1274040
28274163	711	718	studies	T062	C2603343
28274163	727	735	articles	T170	C1706852
28274163	762	770	assessed	T052	C1516048
28274163	793	804	eligibility	T080	C1548635
28274163	809	818	inclusion	T080	C1512693
28274163	826	844	systematic reviews	T170	C1955832
28274163	855	863	Cervical	T082	C0205064
28274163	855	875	Cervical fibronectin	T116,T123	C0016055
28274163	884	894	biomarkers	T201	C0005516
28274163	912	928	highest strength	T081	C1705922
28274163	932	943	association	T067	C0596306
28274163	953	963	occurrence	T079	C2745955
28274163	967	971	SPTB	T033	C3827961
28274163	973	981	delivery	T040	C0005615
28274163	994	996	OR	T081	C0028873
28274163	1012	1020	delivery	T040	C0005615
28274163	1024	1028	days	T079	C0439228
28274163	1030	1032	OR	T081	C0028873
28274163	1050	1082	Maternal serum alpha fetoprotein	T059	C1271652
28274163	1088	1103	associated with	T080	C0332281
28274163	1107	1109	OR	T081	C0028873
28274163	1140	1144	SPTB	T033	C3827961
28274163	1146	1164	C-reactive protein	T116,T129	C0006560
28274163	1172	1174	OR	T081	C0028873
28274163	1216	1224	detected	T033	C0442726
28274163	1228	1236	maternal	T033	C1858460
28274163	1237	1243	plasma	T031	C0032105
28274163	1248	1262	amniotic fluid	T031	C0002638
28274163	1284	1293	cytokines	T116,T129	C0079189
28274163	1295	1308	interleukin-6	T116,T129	C0021760
28274163	1316	1318	OR	T081	C0028873
28274163	1335	1339	SPTB	T033	C3827961
28274163	1357	1365	detected	T033	C0442726
28274163	1369	1377	maternal	T033	C1858460
28274163	1378	1383	serum	T031	C0229671
28274163	1385	1393	Cervical	T082	C0205064
28274163	1394	1411	fetal fibronectin	T116,T123	C0806123
28274163	1413	1430	alpha fetoprotein	T116,T123	C0002210
28274163	1432	1451	C- reactive protein	T116,T129	C0006560
28274163	1456	1469	interleukin 6	T116,T129	C0021760
28274163	1490	1514	good diagnostic accuracy	T080	C0598285
28274163	1530	1549	pregnancies at risk	T046	C0242786
28274163	1553	1557	SPTB	T033	C3827961
28274163	1565	1584	prospective studies	T062	C0033522
28274163	1609	1614	women	T098	C0043210
28274163	1676	1687	serological	T169	C0205473
28274163	1692	1706	imaging marker	T080	C0008963
28274163	1719	1728	antenatal	T079	C2828394
28274163	1729	1739	prediction	T078	C0681842